Company news

EMV Capital PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Resignation of CEO

April 25, 2019

Sale of Wanda and Vortex

March 22, 2019

PDS merger with Edge Therapeutics update

March 19, 2019

PDS completes merger with Edge Therapeutics

March 18, 2019

Share Price Movement

March 14, 2019

Results of General Meeting

March 4, 2019

Update on upcoming General Meeting

March 1, 2019

Conclusion of Strategic Review

February 15, 2019

Glycotest Receives First $3m Tranche from Fosun

February 14, 2019

Termination of Formal Sales Process

January 15, 2019

Update on Strategic Review

December 20, 2018

Amendment to Executive Director Service Terms

November 26, 2018

Vortex Improves CTC Enumeration with Impedance

November 8, 2018

Vortex and STRATEC Announce Global Partnership

November 1, 2018

Glycotest Completes $10m Series A Round with Fosun

October 22, 2018

ProAxsis Immunoassays Selected for Large Trial

September 20, 2018

Wanda Launches CareLink, New Digital Health App

August 15, 2018

ProAxsis Granted Third Respiratory Field CE Mark

August 2, 2018

Wanda Technology Enhancements

July 18, 2018

Bob Englert Appointed CEO of Vortex Biosciences

June 6, 2018

ProAxsis Wins Innovative Business of Year in NI

June 4, 2018

ProAxsis Awarded Invest NI Grant

June 1, 2018

Wanda Announces Significant Data with Partner HRS

May 21, 2018

ProAxsis to Present New Data at ATS 2018

May 2, 2018

Directors Dealing Notification

April 18, 2018

Vortex to Present 2 Posters at AACR

April 16, 2018

Posting of Circular

April 3, 2018

Proposed Placing and Subscription

March 29, 2018

Wanda Expanding to Orthopedic Analytics

March 19, 2018

Vortex Announces Partnership with BioView

March 13, 2018

ProAxsis Reports First NEATstik Sale

February 15, 2018

Vortex Releases Publication in Nature Scientific

February 9, 2018

NetScientific Portfolio Update

January 16, 2018

ProAxsis Achieves CE Mark for Plasmin Immunoassay

January 8, 2018

GlycotestT Completes Diagnostic Evaluation

January 4, 2018

Wanda Awarded Two Patents

December 12, 2017

ProAxsis: Sales Update

November 21, 2017

Vortex Announces First Commercial VTX-1 Sale

November 7, 2017

HRS Expands Use of Wanda to All Patients

November 3, 2017

Glycotest Adds Allowed Chinese Patent to Portfolio

November 2, 2017

Vortex Announces Liquid Biopsy Study in NPJ

November 1, 2017

ProAxsis Showcases ProteaseTag® Research at NACFC

October 30, 2017

ProAxsis Partnership - US National Jewish Health

October 27, 2017

Directorate Change

October 25, 2017

Glycotest Granted Japanese Patent

October 5, 2017

Wanda Awarded US Patent

October 2, 2017

2017 Interim Results

September 28, 2017

ProAxsis appoints Diagenics Limited as Distributor

September 14, 2017

ProAxsis Signs Partnership: Biotechnology Company

September 11, 2017

ProAxsis is awarded a European CE Mark

September 4, 2017

← Newer news releases · Older news releases →

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 15 decks. Every deck is listed under its year.